search
Back to results

Open Technique Interpectoral Catheter for Postoperative Analgesia in Modified Radical Mastectomy

Primary Purpose

Mammary Cancer

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
catheter
iv analgesia
Sponsored by
Istanbul University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Mammary Cancer focused on measuring postoperative analgsia, peripheral block catheter, modified radical mastectomy

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • American Society of Americans Class I-II

Exclusion Criteria:

  • male
  • allergy to local anesthetics or
  • anticoagulant drug use
  • central or peripheric nerve disease
  • pregnancy

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    iv analgesia

    catheter group

    Arm Description

    patients were given intravenously 100 mg of tramadol (contramal) 30 minutes before extubation after modified radical mastectomy.

    patients were placed a catheter under clavipectoral fascia and 30 ml of local anesthetic solution were given via catheter for postoperative analgesia

    Outcomes

    Primary Outcome Measures

    VAS scores
    patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.
    VAS scores
    patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.
    VAS scores
    patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.
    VAS scores
    patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.

    Secondary Outcome Measures

    VAS scores
    patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.

    Full Information

    First Posted
    May 22, 2017
    Last Updated
    February 12, 2018
    Sponsor
    Istanbul University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03204708
    Brief Title
    Open Technique Interpectoral Catheter for Postoperative Analgesia in Modified Radical Mastectomy
    Official Title
    Evaluation of the Postoperative Analgesic Efficacy of Catheter Placed Interpectoral Region Via Open Technique in Patients Undergoing Modified Radical Mastectomy
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    February 2018
    Overall Recruitment Status
    Completed
    Study Start Date
    April 15, 2016 (Actual)
    Primary Completion Date
    February 15, 2017 (Actual)
    Study Completion Date
    February 28, 2017 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Istanbul University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    patients undergoing modified radical mastectomy were divided into two groups. patients in catheter group were placed a catheter with open technique by the surgeon in the pectoral area. thirty minutes before extubation %1 lidocain 10 ml, %0.5 bupivacain 10 ml and 10 ml %0.9 sodium chloride were given through the catheter for postoperative analgesia. patients in iv analgesia group were given 100 mg tramadol iv 30 minutes before extubation. visual analog pain scale (VAS) scores, rescue analgesic requirement, complications were recorded and compared between two groups 1, 6, 12, 24 hours and 90 days after surgery.
    Detailed Description
    patients undergoing modified radical mastectomy were divided into two groups by computer. patients in catheter group were placed a catheter under clavipectoral fascia in the neighbourhood of nervus thoracicus longus, nervus thoracodorsalis, nervus pectoralis lateralis, nervus pectoralis medialis at the 1/3 lateral part of clavicula. solution included 10 ml of %0.5 bupivacain, %1 lidocain, 10 ml %0.9 sodium chloride totally 30 ml were given via the catheter for postoperative analgesia at the end of surgery. patients in iv analgesia group were given 100 mg tramadol iv 30 minutes before extubation. Patients in both groups were given dexketoprofen 50 mg iv if the VAS score was over 4. VAS scores, rescue analgesic requirement and timing, complications were recorded and compared between groups 1, 6, 12, 24 hours and 90 days after surgery.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Mammary Cancer
    Keywords
    postoperative analgsia, peripheral block catheter, modified radical mastectomy

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    86 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    iv analgesia
    Arm Type
    Active Comparator
    Arm Description
    patients were given intravenously 100 mg of tramadol (contramal) 30 minutes before extubation after modified radical mastectomy.
    Arm Title
    catheter group
    Arm Type
    Active Comparator
    Arm Description
    patients were placed a catheter under clavipectoral fascia and 30 ml of local anesthetic solution were given via catheter for postoperative analgesia
    Intervention Type
    Device
    Intervention Name(s)
    catheter
    Intervention Description
    catheter was placed under clavipectoral fascia by open technique by surgeon at the 1/3 lateral part of clavicula neighbourhood of nervus thoracicus longus, nervus thoracodorsalis, nervus pectoralis lateralis, nervus pectoralis medialis
    Intervention Type
    Drug
    Intervention Name(s)
    iv analgesia
    Intervention Description
    patients were given 100 ml of tramadol 30 minutes before extubation
    Primary Outcome Measure Information:
    Title
    VAS scores
    Description
    patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.
    Time Frame
    1 hour after operation
    Title
    VAS scores
    Description
    patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.
    Time Frame
    6 hours after operation
    Title
    VAS scores
    Description
    patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.
    Time Frame
    12 hours after operation
    Title
    VAS scores
    Description
    patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.
    Time Frame
    24 hours after operation
    Secondary Outcome Measure Information:
    Title
    VAS scores
    Description
    patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain.
    Time Frame
    3 months after operation
    Other Pre-specified Outcome Measures:
    Title
    rescue analgesic requirement
    Description
    patients whose VAS scores were over 4 were given 50 mg of dexketoprofen in Group I, 10 ml %0.25 bupivacain in Group II
    Time Frame
    1, 6, 12 and 24 hours after operation

    10. Eligibility

    Sex
    Female
    Gender Based
    Yes
    Gender Eligibility Description
    breast cancer
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    80 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: American Society of Americans Class I-II Exclusion Criteria: male allergy to local anesthetics or anticoagulant drug use central or peripheric nerve disease pregnancy
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    cigdem akyol beyoglu, MD
    Organizational Affiliation
    Istanbul University
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Open Technique Interpectoral Catheter for Postoperative Analgesia in Modified Radical Mastectomy

    We'll reach out to this number within 24 hrs